Byron Creese1, Helen Brooker2, Zahinoor Ismail3, Keith A Wesnes4, Adam Hampshire5, Zunera Khan6, Maria Megalogeni6, Anne Corbett2, Dag Aarsland7, Clive Ballard2. 1. University of Exeter Medical School (BC, HB, KAW, AC, CB), University of Exeter, Exeter, UK. Electronic address: b.creese@exeter.ac.uk. 2. University of Exeter Medical School (BC, HB, KAW, AC, CB), University of Exeter, Exeter, UK. 3. Departments of Psychiatry, Clinical Neurosciences, and Community Health Sciences (ZI), Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada. 4. University of Exeter Medical School (BC, HB, KAW, AC, CB), University of Exeter, Exeter, UK; Wesnes Cognition Ltd. (KAW), Streatley on Thames, UK; Northumbria University (KAW), Newcastle, UK; Swinburne University (KAW), Melbourne; Newcastle University (KAW), Newcastle, UK. 5. Imperial College London (AH), London. 6. King's College London (ZK, MM, DA), London. 7. King's College London (ZK, MM, DA), London; Stavanger University Hospital (DA), Stavanger, Norway.
Abstract
OBJECTIVE: Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for incident cognitive decline and dementia in people with mild cognitive impairment (MCI). We undertook a study to determine whether MBI was associated with progressive changes in neuropsychological performance in people without significant cognitive impairment. METHODS: A total of 9,931 older adults enrolled in the PROTECT study who did not have MCI or dementia undertook a comprehensive neuropsychological battery measuring attention, reasoning, executive function, and working memory at baseline and 1 year. MBI was ascertained using self-administration of the Mild Behavioral Impairment Checklist at 1 year, and participants were grouped according to MBI status: No Symptoms, Intermediate NPS and MBI. All assessments were completed online, and data analyzed using mixed-effects model repeated measures analysis of covariance. RESULTS: A total of 949 (10%) people had MBI. These individuals had significantly worse cognitive performance at baseline and significantly greater decline over 1 year in the four composite cognitive scores measuring attentional intensity (F [2,8578] = 3.97; p = 0.019), sustained attention (F [2,8578] = 18.63; p <0.0001), attentional fluctuation (F [2,8578] = 10.13; p <0.0001) and working memory (F [2,9895] = 13.1; p <0.0001). CONCLUSION: Our novel findings show that MBI is associated with faster decline in attention and working memory in this cognitively normal sample. MBI may be an earlier marker of neurodegenerative disease than MCI, captured at the stage of subjective cognitive decline or before, raising the possibility that MBI represents a novel target for dementia clinical trials or prevention strategies.
OBJECTIVE: Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized by later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for incident cognitive decline and dementia in people with mild cognitive impairment (MCI). We undertook a study to determine whether MBI was associated with progressive changes in neuropsychological performance in people without significant cognitive impairment. METHODS: A total of 9,931 older adults enrolled in the PROTECT study who did not have MCI or dementia undertook a comprehensive neuropsychological battery measuring attention, reasoning, executive function, and working memory at baseline and 1 year. MBI was ascertained using self-administration of the Mild Behavioral Impairment Checklist at 1 year, and participants were grouped according to MBI status: No Symptoms, Intermediate NPS and MBI. All assessments were completed online, and data analyzed using mixed-effects model repeated measures analysis of covariance. RESULTS: A total of 949 (10%) people had MBI. These individuals had significantly worse cognitive performance at baseline and significantly greater decline over 1 year in the four composite cognitive scores measuring attentional intensity (F [2,8578] = 3.97; p = 0.019), sustained attention (F [2,8578] = 18.63; p <0.0001), attentional fluctuation (F [2,8578] = 10.13; p <0.0001) and working memory (F [2,9895] = 13.1; p <0.0001). CONCLUSION: Our novel findings show that MBI is associated with faster decline in attention and working memory in this cognitively normal sample. MBI may be an earlier marker of neurodegenerative disease than MCI, captured at the stage of subjective cognitive decline or before, raising the possibility that MBI represents a novel target for dementia clinical trials or prevention strategies.
Authors: Rachel L Nosheny; Monica R Camacho; Chengshi Jin; John Neuhaus; Diana Truran; Derek Flenniken; Miriam Ashford; Maria C Carrillo; Keith N Fargo; James Hendrix; Lucy Hanna; Gil Rabinovici; Paul Maruff; R Scott Mackin; Michael W Weiner Journal: Alzheimers Dement Date: 2020-07-27 Impact factor: 21.566
Authors: Ganesh M Babulal; Ling Chen; Jason M Doherty; Samantha A Murphy; Ann M Johnson; Catherine M Roe Journal: J Alzheimers Dis Date: 2022 Impact factor: 4.160
Authors: Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard Journal: Nat Rev Neurol Date: 2022-01-04 Impact factor: 44.711
Authors: Sascha Gill; Meng Wang; Pauline Mouches; Deepthi Rajashekar; Tolulope Sajobi; Frank P MacMaster; Eric E Smith; Nils D Forkert; Zahinoor Ismail Journal: Int J Geriatr Psychiatry Date: 2021-04-09 Impact factor: 3.850
Authors: Nicole S Tommasi; Christopher Gonzalez; Danielle Briggs; Michael J Properzi; Jennifer R Gatchel; Gad A Marshall Journal: Int J Geriatr Psychiatry Date: 2021-03-15 Impact factor: 3.850
Authors: Penny A Gosselin; Zahinoor Ismail; Peter D Faris; Carmen L Benkoczi; Tammy L Fraser; Steven W Cherry; Tracey I Faulkner; Md Shariful Islam Journal: Can Geriatr J Date: 2019-09-30
Authors: Harriet A Ball; Laura McWhirter; Clive Ballard; Rohan Bhome; Daniel J Blackburn; Mark J Edwards; Stephen M Fleming; Nick C Fox; Robert Howard; Jonathan Huntley; Jeremy D Isaacs; Andrew J Larner; Timothy R Nicholson; Catherine M Pennington; Norman Poole; Gary Price; Jason P Price; Markus Reuber; Craig Ritchie; Martin N Rossor; Jonathan M Schott; Tiago Teodoro; Annalena Venneri; Jon Stone; Alan J Carson Journal: Brain Date: 2020-10-01 Impact factor: 13.501